Helen Rubenstein
Vice President of Investor Relations and Corporate Strategy at Numora Therapeutics
Replay available
Neumora Therapeutics, Inc. (NMRA) Q4 2025 Earnings Call
Neumora Therapeutics, Inc. (NASDAQ: NMRA) Q4 2025 earnings conference call, held 2026-03-30. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Paul Burns
Chief Executive Officer
Josh Pinto
President
Bill Arora
Chief Operating and Development Officer
Nick Brandon
Chief Scientific Officer
Mike Milligan
Chief Financial Officer
Myles Minter
Analyst at William Blair
Brian Abrahams
Analyst at RBC Capital Markets
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Neumora Therapeutics, Inc..
Replay transcript excerpt
WEBVTT 00:00:00.031 -- 00:00:02.133 Ladies and gentlemen, thank you for standing by. 00:00:02.133 -- 00:00:05.817 At this time, all participants are in a listen-only mode. 00:00:05.817 -- 00:00:09.421 After the speaker's presentation, there'll be a question and answer session. 00:00:09.421 -- 00:00:12.124 Please be advised that today's conference is being recorded. 00:00:12.124 -- 00:00:16.789 I would now like to turn the call over to Helen Rubenstein, Vice President of Investor 00:00:16.789 -- 00:00:19.693 Relations and Corporate Strategy at Numora. 00:00:19.693 -- 00:00:22.193 Please go ahead. 00:00:23.076 -- 00:00:27.241 Good afternoon, and thank you for joining Numora Therapeutics' fourth quarter and full 00:00:27.241 -- 00:00:30.507 year 2025 Financial Results Conference Call. 00:00:30.507 -- 00:00:34.691 Before we begin, I encourage everyone to visit the Investors and Media section of our 00:00:34.691 -- 00:00:37.572 website at numoratx.com, 00:00:37.574 -- 00:00:40.777 where you can find the press release related to today's call. 00:00:40.777 -- 00:00:45.922 With me on the call today are Chief Executive Officer Paul Burns, President Josh 00:00:45.922 -- 00:00:51.127 Pinto, Chief Operating and Development Officer Bill Arora, Chief Scientific Officer 00:00:51.127 -- 00:00:54.670 Nick Brandon, and Chief Financial Officer Mike Milligan. 00:00:54.670 -- 00:00:59.175 I'd like to point out that we will be making forward-looking statements during today's 00:00:59.175 -- 00:01:03.246 call which are based on our current expectations and beliefs. 00:01:03.246 -- 00:01:07.491 These statements are subject to certain risks and uncertainties, and our actual results 00:01:07.491 -- 00:01:12.116 may differ materially. Please review the risk factors discussed in today's press r...